E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -1.58M -1.60M -2.19M -1.70M -3.53M
Total Depreciation and Amortization 5.00K 6.00K 6.00K 7.00K 50.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 262.00K -26.00K -339.00K -5.00K 922.00K
Change in Net Operating Assets 1.00M 258.00K 454.00K -761.00K -218.00K
Cash from Operations -311.00K -1.36M -2.07M -2.46M -2.78M
Capital Expenditure -- -- -- 0.00 0.00
Sale of Property, Plant, and Equipment -- -- -- 0.00 0.00
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- 0.00 0.00
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 0.00 24.00K -- 5.12M 0.00
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 338.00K -338.00K
Cash from Financing 0.00 24.00K -- 5.46M -338.00K
Foreign Exchange rate Adjustments 1.00K 7.00K -8.00K 6.00K 0.00
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -310.00K -1.33M -2.08M 3.01M -3.12M
Weiss Ratings